← Back to search
Literature record

Identification of CSF3R Mutations in B-Lineage Acute Lymphoblastic Leukemia Using Comprehensive Cancer Panel and Next-Generation Sequencing.

PMID 34573308 | PMCID PMC8470887 | DOI 10.3390/genes12091326 · Genes · 2021 · View on PubMed ↗

B-lineage acute lymphocytic leukemia (B-ALL) is characterized by different genetic aberrations at a chromosomal and gene level which are very crucial for diagnosis, prognosis and risk assessment of the disease. However, there is still controversial arguments in regard to disease outcomes in specific genetic abnormalities, e.g., 9p-deletion. Moreover, in absence of cytogenetic abnormalities it is difficult to predict B-ALL progression. Here, we use the advantage of Next-generation sequencing (NGS) technology to study the mutation landscape of 12 patients with B-ALL using Comprehensive Cancer Panel (CCP) which covers the most common mutated cancer genes. Our results describe new mutations in CSF3R gene including S661N, S557G, and Q170X which might be associated with disease progression.

Validated evidence

TypeEntitySource evidenceConfidenceExtractor
geneCSF3R“Identification of CSF3R Mutations in B-Lineage Acute Lymphoblastic Leukemia Using Comprehensive Cancer Panel and Next-Generation Sequencing.”0.98hgnc_dict_v1
phenotypeleukemia“Identification of CSF3R Mutations in B-Lineage Acute Lymphoblastic Leukemia Using Comprehensive Cancer Panel and Next-Generation Sequencing.”0.98phenotype_alias_lexicon_v2
variantS661N“Our results describe new mutations in CSF3R gene including S661N, S557G, and Q170X which might be associated with disease progression.”0.82literature_variant_regex_v2
variantS557G“Our results describe new mutations in CSF3R gene including S661N, S557G, and Q170X which might be associated with disease progression.”0.82literature_variant_regex_v2
variantQ170X“Our results describe new mutations in CSF3R gene including S661N, S557G, and Q170X which might be associated with disease progression.”0.82literature_variant_regex_v2